Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4174126
Max Phase: Preclinical
Molecular Formula: C24H20N2O5
Molecular Weight: 416.43
Molecule Type: Small molecule
Associated Items:
ID: ALA4174126
Max Phase: Preclinical
Molecular Formula: C24H20N2O5
Molecular Weight: 416.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C#CCOC(=O)CC1C(C(=O)OCC#C)=C(N)Oc2ccc(-c3cncc(C)c3)cc21
Standard InChI: InChI=1S/C24H20N2O5/c1-4-8-29-21(27)12-19-18-11-16(17-10-15(3)13-26-14-17)6-7-20(18)31-23(25)22(19)24(28)30-9-5-2/h1-2,6-7,10-11,13-14,19H,8-9,12,25H2,3H3
Standard InChI Key: SYHPEAVSLQOFMY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.43 | Molecular Weight (Monoisotopic): 416.1372 | AlogP: 2.45 | #Rotatable Bonds: 6 |
Polar Surface Area: 100.74 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.24 | CX LogP: 2.72 | CX LogD: 2.72 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.57 | Np Likeness Score: -0.56 |
1. Bian T, Chandagirikoppal Vijendra K, Wang Y, Meacham A, Hati S, Cogle CR, Sun H, Xing C.. (2018) Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells., 61 (15): [PMID:29995404] [10.1021/acs.jmedchem.8b00813] |
Source(1):